wall street

DuPont Fabros Technology has a potential upside of 15.3% based on a current price of $22.95 and an average consensus analyst price target of $26.46.

DuPont Fabros Technology is currently above its 50-day moving average (MA) of $22.19 and should find resistance at its 200-day MA of $23.94.

UBS raised its price target for Dupont Fabros Technology (NYSE:DFT) to $22 from $20 and maintained its neutral rating on the company.

Osiris posted net income of $4.4 million, or 13 cents per share, from a year ago profit of $15.7 million, or 48 cents per share. Analysts expected a profit of 9 cents per share.

Osiris is currently developing a product called Prochymal, which is composed of stem cells taken from adult bone marrow, and is seeking regulatory approval for the product.

Osiris Therapeutics (OSIR) is down 2.33% to $6.70 on a 72% drop in Q4 net income compared with last year, but earnings still topped the mean analyst estimate.

The company also announced it had agreed to buy International Resource Partners LP and its sales and marketing subsidiary Logan & Kanawha Coal Co. for $475 million in cash.

Peter T. Socha, Chairman and CEO of JRCC, commented on the deal: "This is a transformative transaction for James River Coal Company.

James River Coal Company (NASDAQ:JRCC) reported Q4 EPS of $0.14, excluding a one-time tax benefit, vs. consensus estimates for $0.26 per share. Revenues for the quarter were up 8% year-over-year to $162.1 million, below consensus

Steven L. Watson, Vice Chairman and Chief Executive Officer, said, "We saw significant improvement in our business and the TiO2 industry during 2010.

Kronos Worldwide (NYSE:KRO) reported Q4 EPS of $0.66, ahead of consensus estimates of $0.61 per share. Revenues for the quarter rose 24% year-over-year to $373.3 million, missing consensus estimates of $376.6 million.

The bank cited an expectation of better behavioral trends, following UHS' Q4 results, as well as significant benefit from debt refinancing and EBITDA margin expansion.

Universal Health Services has a potential upside of 4.6% based on a current price of $47.79 and an average consensus analyst price target of $50.

Morgan Stanley raised its 2011 EPS estimate for United Health Services (NYSE:UHS) to $3.75 from $3.30, vs. consensus estimates of $3.60 per share, and its 2012 EPS estimate to $4.25 from $3.65, vs. consensus estimates of $4.09 per

The bank revised its 2011 EPS estimate to $3.17 from $3.18, vs. consensus estimates of $3.14 per share, and its 2012 EPS estimate to $3.27 from $3.29, vs. consensus estimates of $3.25 per share.

American Electric Power has a potential upside of 9.4% based on a current price of $35.83 and an average consensus analyst price target of $39.18.

Citigroup lowered its target price for American Electrical Power Co (NYSE:AEP) to $35 from $38 while maintaining its hold rating.

The company has reaffirmed its projection that it will spud 36 net wells during 2011, and that it will produce an average of 6,500 barrels of oil equivalent per day for the year.

Northern Oil and Gas (NYSE:NOG) reported Q4 EPS of $0.13, below consensus estimates of $0.15 per share. Revenues for the quarter were up 54% year-over-year to $23.9 million, slightly below consensus estimates for $24.2 million.

The company sees Q1 EPS of $0.54 to $0.58, vs. consensus estimates of $0.52 per share, and 2011 EPS of $2.62 to $2.85, vs. consensus estimates of $2.51 per share.

Laura Sen, BJ's president and chief executive officer, said, "I am very pleased with our results for the fourth quarter and full year, which reflect continued margin expansion and excellent cost control.

BJ's Wholesale Club (NYSE:BJ) reported Q4 EPS of $0.95, ex-items, ahead of consensus estimates of $0.92 per share. Revenues for the quarter rose 7% year-over-year to $2.90 billion, missing consensus estimates of $2.98 billion.

Joy Global (NASDAQ:JOYG) reported Q1 EPS of $0.96, missing consensus estimates of $1.07 per share.

The company sees Q1 GAAP EPS of $0.30 to $0.32 and 2011 GAAP EPS of $1.50 to $1.60.

Ron Sargent, Staples' chairman and chief executive officer, said, "I'm proud of all that we achieved in 2010. We got back to growing the top-line, achieved solid operating margin expansion and earnings growth, and generated over a

Staples (NASDAQ:SPLS) reported Q4 EPS of $0.39, missing consensus estimates of $0.41 per share. Revenues for the quarter rose less than 1% year-over-year to $6.42 billion, missing consensus estimates of $6.46 billion.